Additionally, we showed that post-MI IFN-α administration increased the infarcted area at day 28 and deteriorated ventricular dilatation, an important predictor of heart failure and ventricular arrhythmia development [27]. This evidence concerns the gene IFNA1 and Ventricular arrhythmia.